The FDA’s requirements for compounding sterile drugs have become more stringent in recent years, especially since 2016, following the addition of section 503B to the 2013 Drug Quality and Security Act ...
FREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today reported strong momentum in the compounding pharmacy ...
Today, the US Food and Drug Administration (FDA) issued a final guidance for the drug compounding industry on the 503B Bulks List, which is a list of bulk drug substances for which there is a clinical ...
Outsourcing facilities, which were developed following passage of the Drug Quality and Security Act of 2013, present an important opportunity for ASCs to boost the quality and efficiency of their care ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Several major ophthalmic organizations requested the FDA ...
There is no question that this year has been challenging for hospitals and health systems. Caring for patients with COVID-19 has led to various drug shortages and other supply chain disruptions after ...
Ottawa, Nov. 12, 2025 (GLOBE NEWSWIRE) -- A recent study by Towards Packaging, a sister firm of Precedence Research, highlights that the U.S. 503B compounding pharmacy packaging market is on a ...
In an effort to provide high-quality, cost-effective care, ASCs rely on outsourced human drug compounding to accommodate specific patient orders. Most centers don’t possess the appropriate staffing or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results